{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:24:46Z","timestamp":1772760286809,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/mot.0b013e32835c2998","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T08:35:57Z","timestamp":1354782957000},"page":"65-70","source":"Crossref","is-referenced-by-count":16,"title":["Generation of mesenchymal stem cells as a medicinal product in organ transplantation"],"prefix":"10.1097","volume":"18","author":[{"given":"Richard","family":"Verbeek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","article-title":"Mesenchymal stem cells as therapeutics.","volume":"12","author":"Parekkadan","year":"2010","journal-title":"Annu Rev Biomed Eng"},{"key":"R2-11-20211004","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease.","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R3-11-20211004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.intimp.2010.06.019","article-title":"The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.","volume":"10","author":"Hoogduijn","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"R4-11-20211004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","article-title":"Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.","volume":"20","author":"Popp","year":"2008","journal-title":"Transpl Immunol"},{"key":"R5-11-20211004","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1432-2277.2011.01328.x","article-title":"In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia.","volume":"24","author":"Hara","year":"2011","journal-title":"Transpl Int"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2005.00573.x","article-title":"Administered mesenchymal stem cells enhance recovery from ischemiareperfusion-induced acute renal failure in rats.","volume":"68","author":"Lange","year":"2005","journal-title":"Kidney Int"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3727\/096368911X623925","article-title":"No adipose tissue-derived stem cell treatment prevent renal disease progression.","volume":"21","author":"Donizetti-Oliveira","year":"2012","journal-title":"Cell Transplant"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/rme.11.28","article-title":"Cell therapy industry: billion dollar global business with unlimited potential.","volume":"6","author":"Mason","year":"2011","journal-title":"Regen Med"},{"key":"R9-11-20211004","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrd3052","article-title":"Challenges with advanced therapy medicinal products and how to meet them.","volume":"9","author":"Schneider","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Developmental Committee of the European Group for Blood and Marrow TransplantationMesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohns disease: results of a phase I study.","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"R12-11-20211004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.intimp.2012.03.024","article-title":"Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells.","volume":"13","author":"Lee","year":"2012","journal-title":"Immunopharmacology"},{"key":"R15-11-20211004","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro.","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3727\/096368910X514260","article-title":"An efficient approach to isolation and characterization of pre and postnatal umbilical cord lining stem cells for clinical applications.","volume":"19","author":"Gonzalez","year":"2010","journal-title":"Cell Transplant"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.","volume":"129","author":"Puissant","year":"2005","journal-title":"Br J Haematol"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2009.07.010","article-title":"Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.","volume":"126","author":"Ivanova-Todorova","year":"2009","journal-title":"Immunol Lett"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/03008200701228464","article-title":"Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.","volume":"48","author":"Bernardo","year":"2007","journal-title":"Connect Tissue Res"},{"key":"R20-11-20211004","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/stem.633","article-title":"Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions.","volume":"29","author":"Roobrouck","year":"2011","journal-title":"Stem Cells"},{"key":"R21-11-20211004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12265-011-9257-3","article-title":"Adult human adipose tissue contains several types of multipotent cells.","volume":"4","author":"Tallone","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"R23-11-20211004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00441-007-0555-7","article-title":"Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies.","volume":"332","author":"Jurgens","year":"2008","journal-title":"Cell Tissue Res"},{"key":"R24-11-20211004","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1634\/stemcells.2004-0331","article-title":"Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"R26-11-20211004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/14653249.2011.594792","article-title":"Mesenchymal stromal cells impair the differentiation of CD14CD16CD64 classical monocytes into CD14CD16CD64 activate monocytes.","volume":"14","author":"Du Rocher","year":"2012","journal-title":"Cytotherapy"},{"key":"R27-11-20211004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/14653249.2011.640669","article-title":"Population dynamics of mesenchymal stromal cells during culture expansion.","volume":"14","author":"Schellenberg","year":"2012","journal-title":"Cytotherapy"},{"key":"R28-11-20211004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy.","volume":"18","author":"Von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R29-11-20211004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5966\/sctm.2011-0011","article-title":"The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells.","volume":"1","author":"Lennon","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"R30-11-20211004","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.exphem.2008.03.019","article-title":"Effects of plating density and culture time on bone marrow stromal cell characteristics.","volume":"36","author":"Neuhuber","year":"2008","journal-title":"Exp Hematol"},{"key":"R31-11-20211004","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1634\/stemcells.20-6-530","article-title":"Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality.","volume":"20","author":"Sekiya","year":"2002","journal-title":"Stem Cells"},{"key":"R32-11-20211004","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jor.22057","article-title":"Effect of age and gender on cell proliferation and cell surface characterization of synovial fat pad derived mesenchymal stem cells.","volume":"30","author":"Fossett","year":"2012","journal-title":"J Orthopaed Res"},{"key":"R33-11-20211004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14653240902736266","article-title":"Effect of growth media and serum replacements on the proliferation and differentiation of adipose-derived stem cells.","volume":"11","author":"Lund","year":"2009","journal-title":"Cytotherapy"},{"key":"R34-11-20211004","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/14653249.2010.501788","article-title":"Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells.","volume":"12","author":"Horn","year":"2010","journal-title":"Cytotherapy"},{"key":"R35-11-20211004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10875-011-9581-z","article-title":"Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.","volume":"31","author":"Flemming","year":"2011","journal-title":"J Clin Immunol"},{"key":"R36-11-20211004","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3324\/haematol.2010.038356","article-title":"Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase III clinical trial.","volume":"96","author":"Perez-Simon","year":"2011","journal-title":"Haematologica"},{"key":"R37-11-20211004","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/14653240903233081","article-title":"Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro.","volume":"11","author":"Lindroos","year":"2009","journal-title":"Cytotherapy"},{"key":"R38-11-20211004","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/14653249.2012.684379","article-title":"Evaluation of methods for cultivating limbal mesenchymal stromal cells.","volume":"14","author":"Bray","year":"2012","journal-title":"Cytotherapy"},{"key":"R39-11-20211004","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Societe Francaise de Greffe de Moelle et Therapie CellulaireClinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation.","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"key":"R41-11-20211004","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","article-title":"Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.","volume":"67","author":"Bernardo","year":"2007","journal-title":"Cancer Res"},{"key":"R43-11-20211004","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/scd.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.","volume":"20","author":"Ra","year":"2011","journal-title":"Stem Cells Dev"},{"key":"R44-11-20211004","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/scd.2008.0255","article-title":"Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture.","volume":"18","author":"Grimes","year":"2009","journal-title":"Stem Cells Dev"},{"key":"R45-11-20211004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1479-5876-9-124","article-title":"Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation - a phase I study (MISOT-I).","volume":"9","author":"Popp","year":"2011","journal-title":"J Transl Med"},{"key":"R46-11-20211004","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/ten.tec.2011.0255","article-title":"Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.","volume":"17","author":"Santos","year":"2011","journal-title":"Tissue Eng Part C Methods"},{"key":"R47-11-20211004","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jctb.1918","article-title":"Design of bioreactors for mesenchymal stem cell tissue engineering.","volume":"83","author":"Godara","year":"2008","journal-title":"J Chem Technol Biotechnol"},{"key":"R48-11-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/ten.tec.2009.0432","article-title":"Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.","volume":"16","author":"Frith","year":"2010","journal-title":"Tissue Eng Part C Methods"},{"key":"R49-11-20211004","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method.","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp Hematol"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201302000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T10:05:06Z","timestamp":1633514706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201302000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e32835c2998","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}